![](https://cdn.sanity.io/images/0vv8moc6/psychtimes/ab16f55a19460639646149c79950a844fb75612a-6144x3072.jpg?fit=crop&auto=format)
Xanomeline-Trospium as a Novel Agent for Treatment of Psychosis in Schizophrenia
TRANSLATING RESEARCH INTO PRACTICE Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP, Column Editor A monthly column dedicated to reviewing the literature and sharing clinical implications. Xanomeline is a synthetic muscarinic receptor agonist that binds …